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Fibronectin was chromatographed on immobilized alkanes of various chain lengths. No binding of the 
protein to the hydrophobic matrix was observed with alkanes containing from 3-7 methylene groups; the 
protein bound, however, to immobilized alkanes with 8 or 10 methylene groups. Fibronectin could be 
quantitatively eluted from commercial Octylsepharose with a non-ionic detergent. A gelatin-based plasma 
expander did not interfere with the binding. Many proteolytic fibronectin fragments also bound to a 
hydrophobic matix. The results show that fibronectin posesses at least one hydrophobic binding site. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
Plasma fibronectin is a large glycoprotein (W 
440000), consisting of 2 similar, disulfide-linked 
subunits. It has been shown to bind to numerous 
macromolecules (collagen, Clq, heparin, actin, 
fibrin(ogen), DNA) as well as to cell surfaces. 
Various domains containing one or more binding 
sites have been identified by enzymatic degrada- 
tion. Fibronectin seems to be involved in cell ad- 
hesion and spreading, cell motility, and phagocyto- 
sis. Numerous recent publications have reviewed 
the various aspects of fibronectin structure and 
function [l-5]. 
Binding of fibronectin to gelatin might involve 
hydrophobic interactions [6]; furthermore, hydro- 
phobic interactions of fibronectin with artificial 
surfaces have been postulated [7,8]; we therefore 
thought it might be interesting to investigate the 
binding of purified fibronectin to hydrophobic 
matrices under conditions that can be strictly 
defined. 
Abbreviations: PBS, phosphate-buffered saline; DTT, 
dithiothreitol; PMSF, benzyl sulfonyl fluoride; SDS, 
sodium dodecyl sulfate; PAGE, polyacrylamide gel elec- 
trophoresis. 
Octylsepharose and Phenylsepharose were pur- 
chased from Pharmacia; 1.5 x 6 cm columns were 
packed and equilibrated with PBS (7.34 mmol 
NazHPO.+, 2.68 mmol NaHzP04,142 mmol NaCl, 
0.5 g NaNj, 1 1 Hz0 (pH 7.15)). Desorption of 
bound proteins and peptides was achieved with a 
O-l% or 0-2070 gradient of Brij 35 (poly(ethylene 
glycol)monolauryl ether, M, - 900; Serva) in PBS. 
In some experiments very tightly bound material 
was desorbed with 8 mol/l urea in PBS. Between 
runs, the columns were regenerated by sequential 
purges with water, ethanol, 1-butanol, ethanol, 
water, and PBS, following the manufacturer’s 
recommendations. 
Alkane-Sepharoses with hydrophobic chains of 
various lengths were prepared by activating Sepha- 
rose CL-4B (Pharmacia) with CNBr, then coupling 
1-aminoalkanes to it [9-l 11. As an altenative, the 
Sepharose was activated with s-trichlorotriazine 
[12]; displacement of the second chlorine of the 
s-trichlorotriazine with aniline was omitted; rather, 
1-aminoalkanes, dissolved in dioxane, were directly 
coupled to the activated gel. 
Fibronectin was purified by affinity chromato- 
graphy on immobilized gelatin, essentially accor- 
ding to [ 131. Fibronectin-containing fractions were 
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concentrated by ultrafiltration, then dialyzed 
against 75% glycerol in PBS; stable solutions con- 
taining -5% fibronectin were obtained. For cer- 
tain experiments, less purified fibronectin prepara- 
tions were obtained by glycine and ethanol precipi- 
tation [14]. Source material for these preparations 
was either human plasma, obtained from routine 
blood donations taken into titrated anticoagulant, 
or cryoprecipitate prepared from this plasma. The 
plasma left over after fibronectin adsorption was 
used as a source of fibronectin-free plasma. 
Enzymatic degradation of fibronectin was car- 
ried out on 1.3 ml aliquots, containing 5 mg fibro- 
nectin in PBS with 6% glycerol; 125,ug &chymo- 
trypsin (Sigma) were added to the sample, which 
was then incubated at 37°C. After the incubation, 
200~1 were withdrawn and processed for electro- 
phoresis. To the remainder, 20~1 0.2mol/l PMSF 
in isopropanol were added, and the sample was im- 
mediately loaded on an Octylsepharose column. 
A Laemmli system [15] was used for electro- 
phoresis in the presence of SDS and under reducing 
conditions. The stacking gel contained 3%, the 
separating el 7.5% polyacrylamide. The gels were 
silver stained according to [16]. 
Anti-human fibronectin antibodies were raised 
in rabbits; the rabbit immune serum was adsorbed 
with fibronectin-free human plasma [17] and used 
for the assay of fibronectin by a laser nephelo- 
metric technique; measurements were made with a 
Hyland PDQ nephelometer. 
Physiogel is the brand name of a gelatin-based 
plasma expander; this chemically degraded ma- 
terial has av. iK 20000. 
3. RESULTS 
Fig. 1 shows the elution patterns obtained when 
fibronectin solutions are passed over alkane-seph- 
arose columns. Retention of fibronectin obviously 
strongly depends on the chain length of the alkane; 
no binding is observed with propyl- to heptyl- 
Sepharose (fig. la-c), while complete binding 
occurs with octyl- and decylSepharose (fig. ld,e). 
Some of the fibronectin can be desorbed with 
detergent from octyl-Sepharose, none from decyl- 
Sepharose; in both cases, the fibronectin can be 
desorbed with 8 mol urea/l. When commercial 
Octylsepharose was used (fig. If), the protein was 
also completely retained by the gel; this time, how- 
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Fig. 1. Chromatography of -4 mg fibronectin on al- 
kane-Sepharoses of various chain lengths. The samples 
were loaded at 0 volume; B indicates the beginning of 
elution with a O-2% Brij 35 gradient in PBS, U the 
beginning of elution with 8 mol urea/l in PBS. The chain 
length of the I-aminoalkane coupled to the activated 
Sepharose was: (a) C3; (b) C6; (c) C7; (d) C8; (e) ClO; 
(f) commercial Octylsepharose used. 
ever, elution of fibronectin with a Brij 35 gradient 
was complete and gave a sharp peak. Further ex- 
periments were carried out with commercial Octyl- 
sepharose. 
The fibronectin samples that were tested all ex- 
hibited the same behavior on commercial Octyl- 
sepharose, whether they had been isolated by 
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affinity chromatography or by precipitation, or 
whether they were applied to the columns as a pure 
protein or mixed with other plasma proteins (e.g., 
human albumin). 
In another series of experiments, fibronectin was 
enzymatically digested for various lengths of time 
with S-chymotrypsin; chromatography on Octyl- 
sepharose separated the digests into a binding and 
a non-binding fraction. Electrophoretic patterns of 
two digests and of the corresponding binding and 
non-binding fractions are shown in fig. 2. In 
general, large peptides are bound by the column 
while small ones are not; the assignment of bands 
that persist in both the 5 min and 1 h digest to the 
binding or non-binding fraction is, however, not 
always unequivocal. 
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Fig. 2. SDS-PAGE of fibronectin degradation pro- 
ducts: (a) undegraded fibronectin; (b-d) 5 min digest; 
(e-g) 1 h digest; (b,e) total digests; (c,f) non-bound 
fractions; (d,g) bound fractions. The M, markers are 
(~10~~): 94, phosphorylase b; 67, albumin; 43, oval- 
bumin; 30, carbonic anhydrase; 20.1, trypsin inhibitor. 
4. DISCUSSION 
Fibronectin has at least one hydrophobic binding 
site; its most striking feature is the strong depen- 
dence of this binding site on the chain length of the 
immobilized alkane: while no binding occurs with 
immobilized heptane, complete binding was ob- 
served with octane. This is in contrast with obser- 
vations made with various enzymes, where a pro- 
gressively stronger binding with increasing chain 
length was found [11,18,19]. It is also remarkable 
that commercial Octylsepharose gives different 
results from octyl-Sepharose prepared in the 
laboratory; this might have to do with the linking 
of the hydrocarbon chain with the solid support. If 
1-aminoalkanes are coupled to activated Sepha- 
rose, the link between the matrix and the hydro- 
carbon chain consists of only a few atoms; in com- 
mercial Octylsepharose, on the other hand, there is 
a spacer (hydrophilic) of 5 atoms between the 
matrix and the hydrocarbon. Hydrophobic sup- 
ports made by coupling of 1-aminoalkanes to s-tri- 
chlorotriazine-activated Sepharose seemed to bind 
fibronectin even more strongly, possibly due to the 
presence of a heterocyclic ring and/or 2 closely 
located hydrophobic chains. It could also be shown 
that fibronectin binds to Phenylsepharose and may 
be desorbed from it under conditions similar to 
those described for alkane-Sepharoses (not 
shown). 
We found that binding of fibronectin to Octyl- 
sepharose is independent of its binding to gelatin: 
the presence of 1% Physiogel, which binds to 
fibronectin ([20]; own observations), does not pre- 
vent binding of fibronectin to the hydrophobic car- 
rier, nor does it desorb already bound protein. The 
hydrophobic binding sites are, on the other hand, 
dependent on structures maintained by disulfide 
bonds, since we found that reduction of the mole- 
cule with DTT causes stronger binding to Octyl- 
sepharose (not shown). 
Peptides derived by proteolytic digestion from 
fibronectin also bind to Octylsepharose; the large 
number of fragments that were found to bind 
suggests that additional binding sites are created 
by the structural loss caused by proteolysis. Not 
all peptides were located unambiguously in the 
binding or non-binding fractions. This might mean 
that, in the complex mixture obtained by digestion, 
some fragments may or may not be part of larger 
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aggregates held together by non-covalent bonds; 
these aggregates are then retained by the hydro- 
phobic matrix and fall apart when electrophoresed 
in the presence of SDS and 2-mercaptoethanol. 
Binding of fibronectin to Octylsepharose, at 
least under the conditions employed here, is not 
sufficiently selective to permit a substantial purifi- 
cation; e.g., when starting from plasma or cryopre- 
cipitate. It might, however, be a useful additional 
tool for the purification of fragments or as a struc- 
tural probe for the intact molecule. A possible 
biological significance of the hydrophobic binding 
site(s) and their localization on the fibronectin 
molecule remain to be elucidated. 
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